Table 3 TNM stadia of detected CRCs
Total (n = 78) | MLH1 (n = 37) | MSH2 (n = 23) | MSH6 (n = 12) | PMS2 (n = 6) | P-value | |
|---|---|---|---|---|---|---|
Tumor | 0.151 | |||||
Intramucosal | 1 (3%) | 0 | 0 | 1 (8%) | 0 | |
T1 (%) | 25 (32%) | 10 (27%) | 12 (52%) | 1 (8%) | 2 (33%) | |
T2 (%) | 19 (24%) | 11 (30%) | 4 (17%) | 3 (25%) | 1 (17%) | |
T3 (%) | 27 (35%) | 11 (30%) | 7 (30%) | 7 (58%) | 2 (33%) | |
T4 (%) | 3 (4%) | 3 (8%) | 0 | 0 | 0 | |
Node | 0.283 | |||||
N0 (%) | 57 (73%) | 29 (78%) | 18 (78%) | 7 (58%) | 3 (50%) | |
N1 (%) | 11 (14%) | 3 (8%) | 4 (17%) | 3 (25%) | 1 (17%) | |
N2 (%) | 7 (9%) | 3 (8%) | 1 (4%) | 2 (17%) | 1 (17%) | |
Metastasis | 0.122 | |||||
M0 (%) | 74 (95%) | 35 (95%) | 23 (100%) | 11 (92%) | 5 (83%) | |
M1 (%) | 1 (1%) | 0 | 0 | 1 (8%) | 0 |